158 related articles for article (PubMed ID: 23529028)
61. In Vitro Activity of 3-Triazeneindoles against Mycobacterium tuberculosis and Mycobacterium avium.
Nikonenko BV; Kornienko A; Majorov K; Ivanov P; Kondratieva T; Korotetskaya M; Apt AS; Salina E; Velezheva V
Antimicrob Agents Chemother; 2016 Oct; 60(10):6422-4. PubMed ID: 27503657
[TBL] [Abstract][Full Text] [Related]
62. Synthesis, in vitro antimycobacterial and antibacterial evaluation of IMB-070593 derivatives containing a substituted benzyloxime moiety.
Wei Z; Wang J; Liu M; Li S; Sun L; Guo H; Wang B; Lu Y
Molecules; 2013 Mar; 18(4):3872-93. PubMed ID: 23538901
[TBL] [Abstract][Full Text] [Related]
63. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
Woodley CL; Kilburn JO
Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
[TBL] [Abstract][Full Text] [Related]
64. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
[TBL] [Abstract][Full Text] [Related]
65. In vitro activity of 12 antimicrobial peptides against Mycobacterium tuberculosis and Mycobacterium avium clinical isolates.
Portell-Buj E; Vergara A; Alejo I; López-Gavín A; Monté MR; San Nicolás L; González-Martín J; Tudó G
J Med Microbiol; 2019 Feb; 68(2):211-215. PubMed ID: 30570475
[TBL] [Abstract][Full Text] [Related]
66. Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis.
Heifets LB; Lindholm-Levy PJ; Flory M
Am Rev Respir Dis; 1991 Feb; 143(2):268-70. PubMed ID: 1899326
[TBL] [Abstract][Full Text] [Related]
67. Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii.
Alcaide F; Calatayud L; Santín M; Martín R
Antimicrob Agents Chemother; 2004 Dec; 48(12):4562-5. PubMed ID: 15561826
[TBL] [Abstract][Full Text] [Related]
68. Novel phthalazinyl derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis isocitrate lyase enzyme.
Sriram D; Yogeeswari P; Senthilkumar P; Dewakar S; Rohit N; Debjani B; Bhat P; Veugopal B; Pavan VV; Thimmappa HM
Med Chem; 2009 Sep; 5(5):422-33. PubMed ID: 19534678
[TBL] [Abstract][Full Text] [Related]
69. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.
Gay JD; DeYoung DR; Roberts GD
Antimicrob Agents Chemother; 1984 Jul; 26(1):94-6. PubMed ID: 6236748
[TBL] [Abstract][Full Text] [Related]
70. Synthesis and Antimicrobial Evaluation of 6-Alkylamino-N-phenylpyrazine-2-carboxamides.
Servusova-Vanaskova B; Paterova P; Garaj V; Mandikova J; Kunes J; Naesens L; Jílek P; Dolezal M; Zitko J
Chem Biol Drug Des; 2015 Oct; 86(4):674-81. PubMed ID: 25676890
[TBL] [Abstract][Full Text] [Related]
71. Synthesis and antimycobacterial activity of 2-substituted halogenobenzimidazoles.
Kazimierczuk Z; Andrzejewska M; Kaustova J; Klimesova V
Eur J Med Chem; 2005 Feb; 40(2):203-8. PubMed ID: 15694655
[TBL] [Abstract][Full Text] [Related]
72. New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis.
Shahjahan Kabir M; Engelbrecht K; Polanowski R; Krueger SM; Ignasiak R; Rott M; Schwan WR; Stemper ME; Reed KD; Sherman D; Cook JM; Monte A
Bioorg Med Chem Lett; 2008 Nov; 18(21):5745-9. PubMed ID: 18849164
[TBL] [Abstract][Full Text] [Related]
73. Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: pharmacophore identification based on the screening hit closantel.
Hlasta DJ; Demers JP; Foleno BD; Fraga-Spano SA; Guan J; Hilliard JJ; Macielag MJ; Ohemeng KA; Sheppard CM; Sui Z; Webb GC; Weidner-Wells MA; Werblood H; Barrett JF
Bioorg Med Chem Lett; 1998 Jul; 8(14):1923-8. PubMed ID: 9873460
[TBL] [Abstract][Full Text] [Related]
74. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Zuo GY; Zhang XJ; Han J; Li YQ; Wang GC
BMC Complement Altern Med; 2015 Dec; 15():425. PubMed ID: 26627468
[TBL] [Abstract][Full Text] [Related]
75. Comparison of the activities of the lantibiotics nisin and lacticin 3147 against clinically significant mycobacteria.
Carroll J; Draper LA; O'Connor PM; Coffey A; Hill C; Ross RP; Cotter PD; O'Mahony J
Int J Antimicrob Agents; 2010 Aug; 36(2):132-6. PubMed ID: 20547041
[TBL] [Abstract][Full Text] [Related]
76. Synthesis and in vitro evaluation of the antitubercular and antibacterial activity of novel oxazolidinones bearing octahydrocyclopenta[c]pyrrol-2-yl moieties.
Bhattarai D; Lee JH; Seo SH; Nam G; Choo H; Kang SB; Kwak JH; Oh T; Cho SN; Pae AN; Kim EE; Jeong N; Keum G
Chem Pharm Bull (Tokyo); 2014; 62(12):1214-24. PubMed ID: 25297523
[TBL] [Abstract][Full Text] [Related]
77. [Relation between chemical structure and antimycobacterial activity against atypical strains. XIII. Thiosalicylanilides].
Waisser K; Kubicová L; Gregor J; Budová J; Andrlová A; Drsata J; Odlerová Z
Ceska Slov Farm; 1998 Mar; 47(2):84-6. PubMed ID: 9650366
[TBL] [Abstract][Full Text] [Related]
78. Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Malasala S; Ahmad MN; Akunuri R; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2021 Feb; 212():112996. PubMed ID: 33190958
[TBL] [Abstract][Full Text] [Related]
79. [In vitro activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis, M. avium, M. africanum, M. kansasii and BCG strains].
Thomas L; Naumann P; Crea A
Immun Infekt; 1986 Nov; 14(6):203-7. PubMed ID: 3100424
[TBL] [Abstract][Full Text] [Related]
80. Synthesis and in vitro antimycobacterial and isocitrate lyase inhibition properties of novel 2-methoxy-2'-hydroxybenzanilides, their thioxo analogues and benzoxazoles.
Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Wsól V; Vinšová J
Eur J Med Chem; 2012 Oct; 56():108-19. PubMed ID: 22960697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
